GlassScriptPhysician profile
Brittany Smith
NPI 1124616933
$1,949.73
in general payments reported to CMS, 2019-2025
17 companies · $34.86 in 2025
The $34.86 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $129 · 2022: $108 · 2023: $137 · 2024: $1,541 · 2025: $34.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,713.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $1,541.16 | 2024 | M22 |
| Gilead Sciences, INC. | $76.10 | 2021-2025 | Biktarvy |
| Horizon Therapeutics Plc | $71.64 | 2021-2022 | |
| Radius Health, INC. | $32.31 | 2023 | Tymlos |
| Novo Nordisk INC | $28.84 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $25.11 | 2023 | Flumist Quadrivalent |
| Axonics, INC. | $20.79 | 2023 | Axonics |
| Abbvie INC. | $19.27 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $18.45 | 2021 | |
| Amgen INC. | $18.09 | 2022 | |
| Viiv Healthcare Company | $17.49 | 2021 | |
| Glaxosmithkline, LLC. | $16.62 | 2023 | Trelegy Ellipta |
| Sanofi Pasteur INC. | $15.33 | 2023 | |
| Convatec INC. | $14.03 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $13.24 | 2023 | Abilify Maintena, Rexulti |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.84 | 2021 | |
| Genentech, INC. | $9.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.